Literature DB >> 2601719

The 5' noncoding region of the human leukemia-associated oncogene BCR/ABL is a potent inhibitor of in vitro translation.

A J Muller1, O N Witte.   

Abstract

The mRNA encoding the chimeric BCR/ABL oncogene, which is transcribed from the Philadelphia chromosome in human chronic myelogenous leukemia, has a 5' noncoding sequence greater than 500 bases in length which is highly GC rich and contains a short open reading frame. This untranslated sequence has a dramatic inhibitory effect upon translational efficiency in vitro. However, when BCR/ABL message is expressed in certain cell types such as the NIH 3T3 cell line, the 5' noncoding region has little inhibitory effect on translational efficiency.

Entities:  

Mesh:

Year:  1989        PMID: 2601719      PMCID: PMC363679          DOI: 10.1128/mcb.9.11.5234-5238.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic mRNA reduces translational efficiency.

Authors:  J Pelletier; N Sonenberg
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

Review 2.  Activation of the abl oncogene in murine and human leukemias.

Authors:  J B Konopka; O N Witte
Journal:  Biochim Biophys Acta       Date:  1985-11-12

3.  Bifunctional messenger RNAs in eukaryotes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

4.  Recognition of cap structure in splicing in vitro of mRNA precursors.

Authors:  M M Konarska; R A Padgett; P A Sharp
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

5.  Effect of upstream reading frames on translation efficiency in simian virus 40 recombinants.

Authors:  D S Peabody; S Subramani; P Berg
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

6.  Termination-reinitiation occurs in the translation of mammalian cell mRNAs.

Authors:  D S Peabody; P Berg
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

7.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

8.  Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.

Authors:  J B Konopka; S M Watanabe; J W Singer; S J Collins; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products.

Authors:  J B Konopka; O N Witte
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

10.  Influences of mRNA secondary structure on initiation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  12 in total

1.  Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA.

Authors:  A A Haller; B L Semler
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Unique organization of the human BCR gene promoter.

Authors:  Q S Zhu; N Heisterkamp; J Groffen
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 3.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

4.  Identification of the promoter region of human interleukin 1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression.

Authors:  K Ye; C A Dinarello; B D Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

5.  The translation in vitro of rat ornithine decarboxylase mRNA is blocked by its 5' untranslated region in a polyamine-independent way.

Authors:  H Van Steeg; C T Van Oostrom; H M Hodemaekers; L Peters; A A Thomas
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

6.  Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.

Authors:  A M Pendergast; A J Muller; M H Havlik; R Clark; F McCormick; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

7.  Domains within the mammalian ornithine decarboxylase messenger RNA have evolved independently and episodically.

Authors:  G J Johannes; F G Berger
Journal:  J Mol Evol       Date:  1993-06       Impact factor: 2.395

8.  Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines.

Authors:  N P Shah; O N Witte; C T Denny
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

9.  Developmental regulation and neuronal expression of the mRNA of rat n-chimaerin, a p21rac GAP:cDNA sequence.

Authors:  H H Lim; G J Michael; P Smith; L Lim; C Hall
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

Review 10.  The discovery of placenta growth factor and its biological activity.

Authors:  Sandro De Falco
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.